Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Raily Aesthetic Medicine International Holdings Limited announced the disposal of its subsidiary, Jiumei Xinhe, resulting in an estimated net loss of RMB740.55. The proceeds from this transaction will be utilized as general working capital for the company. This move reflects the company’s strategic adjustments amidst challenging financial conditions.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.